Compare Apartment Investment and Management Co (AIV) vs CVS Health Corp (CVS) Price & Performance

AIV trades at $2.66, up 0.38% on the day, with a bearish technical signal from moving averages. The company reported a net income margin of 400.05% in 2025, driven by a significant tax benefit, though revenue declined to $138.49 million. Earnings history shows mixed quarterly results, with two beats and two misses against expectations. Analyst consensus is mixed with a hold rating from two of three analysts.

The outlook is cautious due to volatile earnings and declining revenue, offset by strong profitability metrics and a dividend announcement. Key risks include inconsistent financial performance and high debt levels. Upside potential exists if the company stabilizes revenue growth and maintains improved margins.

CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.

The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.